je.st
news
Tag: development
Title 11 Monitoring Presentation - Development
2015-11-04 17:34:51| PortlandOnline
PDF Document, 503kbCategory: November 2015
Tags: title
development
presentation
monitoring
TDM/TLM Software supports Industry 4.0 development.
2015-11-04 14:31:06| Industrial Newsroom - All News for Today
Advancing Tool Data Management (TDM) towards Tool Lifecycle Management (TLM), TDM v4.8 offers multi-tool support in TDM Base Module, data import from MachiningCloud, wireless connection for barcode scanners in TDM Tool Crib module, and at-a-glance CAM data for operator. Functionality accelerates and facilitates generation of solid models for tool assemblies, and menu tab in tool assembly management shows CAM programmer required tool parameters. Solid models are compatible with CAM system.
Tags: software
development
industry
supports
Sustainability: The New Norm in Real Estate Development and Investing
2015-11-04 09:00:00| National Real Estate Investor
Time was when the idea of sustainability in real estate development and investing was a pretty soft notion. Today, things are vastly different, and its the bottom line thats talking. read more
Tags: real
development
estate
investing
Continental Resources Features Keysight Technologies Test Equipment for Next Generation RF / Microwave Product Development
2015-11-03 11:31:12| Industrial Newsroom - All News for Today
Continental Resources (ConRes) Test and Measurement Division features Keysight Technology's (formerly Agilent) signal analyzers (spectrum analyzers), network analyzers, and signal generators for next generation RF/microware product development. The advanced test equipment supports design and test of RFIC (Radio...
Tags: product
development
features
resources
Acceleron Highlights Phase 3 Studies, New Clinical Results And Research Strategies At Research And Development Day Event
2015-11-03 04:51:04| drugdiscoveryonline Home Page
Acceleron Pharma Inc., a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic candidates that regulate cellular growth and repair, recently announced the phase 3 clinical trial designs for the luspatercept program in myelodysplastic syndromes (“MEDALIST” study) and beta-thalassemia (“BELIEVE” study), phase 1 preliminary results from the ACE-083 program, and its new IntelliTrapdrug discovery platform
Tags: day
results
research
development
Sites : [394] [395] [396] [397] [398] [399] [400] [401] [402] [403] [404] [405] [406] [407] [408] [409] [410] [411] [412] [413] next »